As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
Image credit: Clinical Imaging Systems GCMI, the U.S. proving ground for medtech innovation, has recently acquired a GE LightSpeed VCT 64 Slice CT Scanner with cardiac gating capabilities. “The ability for these machines to generate 3D images of anatomic structures and organs in a pre-op, post-op or intra-operative scenario, including cardiac and vascular imaging, has…
The Center for Global Health Innovation (CGHI) recently announced the winners of its 2023 Golden Helix Awards. Congratulations to GCMI’s CEO, Sherry Farrugia, recipient of the 2023 Industry Growth Awards for her impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by CGHI. …
If you’re attending ORS 2023 and have a new orthopedic technology in development, including preclinical work that may be on your product development horizon, you have a wonderful chance to connect with our Director of Scientific Affairs Evan Goldberg onsite. GCMI is the U.S. proving ground for global medical innovation. Our mission is to…
Our colleague Chris Rozell, Professor and Julian T. Hightower Chair,Technical Interest Groups: Bioengineering, Digital Signal Processing at Georgia Tech asked us to share the following career opportunity advancing research and education in neuroscience. We hope this initiative and position will have the opportunity to work closely with GCMI in the future. From Chris: Georgia Tech…
GCMI, a non-profit affiliate of the Georgia Institute of Technology, is actively recruiting for a research engineer to lead multiple new medtech product development projects. The medical device design services and product development team at GCMI facilitates medical product development through all phases – from initial concept generation through transfer to production manufacturing. We…
“Because we followed a solid pathway, we had a lot more latitude to make positive changes that should increase the likelihood of clinical utility and positive patient impact for our device.”
Quick Insights Aligned in Acceleration: Indeed, the Most Expensive Preclinical Study is the One You Have to Do Twice As mentioned in a post last month, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways, all of which center around actionable insights generation and insights management. …
Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells. Because…
Life science companies of all shapes and sizes rely on preclinical contract research organizations (CROs) to generate the data and reports required to bring their innovations to market. To do this effectively, and in a capital efficient manner, each entity needs to understand what they need from the other, when they need it, why…
As we shared recently, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…